Key Metrics
SJR 

Q4Nursing (all)

Recommended pre-submission checks
Powered by 

Metas de Enfermeria Journal Specifications
Indexed in the following public directories
Scopus
SJR
| Overview | |
| Publisher | DAE Editorial, Grupo Paradigma |
Planning to publish in Metas de Enfermeria ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Metas de Enfermeria
Artificial and Other Non-Nutritive Sweeteners, the Microbiome, and Cardiometabolic Health.
- 25 Jun 2026
- Current atherosclerosis reports
Single-cell Technologies in Atherosclerosis: Uncovering Cellular Heterogeneity, Mechanisms, and Therapeutic Opportunities.
- 18 Jun 2026
- Current atherosclerosis reports
Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
- 12 Jun 2026
- Current atherosclerosis reports
Familial Hypercholesterolemia in Women: Diagnosis, Treatment, and Cardiovascular Outcomes Across the Lifespan.
- 8 Jun 2026
- Current atherosclerosis reports
Micro-and Nano-Plastic Exposure as an Emerging Risk for Atherosclerotic Cardiovascular Disease.
- 5 Jun 2026
- Current atherosclerosis reports
Old and New Lines of Therapy Targeting Lipoprotein(a).
- 3 Jun 2026
- Current atherosclerosis reports
Artificial and Other Non-Nutritive Sweeteners, the Microbiome, and Cardiometabolic Health.
- 25 Jun 2026
- Current atherosclerosis reports
Single-cell Technologies in Atherosclerosis: Uncovering Cellular Heterogeneity, Mechanisms, and Therapeutic Opportunities.
- 18 Jun 2026
- Current atherosclerosis reports
Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
- 12 Jun 2026
- Current atherosclerosis reports
Familial Hypercholesterolemia in Women: Diagnosis, Treatment, and Cardiovascular Outcomes Across the Lifespan.
- 8 Jun 2026
- Current atherosclerosis reports
Micro-and Nano-Plastic Exposure as an Emerging Risk for Atherosclerotic Cardiovascular Disease.
- 5 Jun 2026
- Current atherosclerosis reports
Old and New Lines of Therapy Targeting Lipoprotein(a).
- 3 Jun 2026
- Current atherosclerosis reports